With BakerHostetler as lead counsel, Surge Private Equity has entered into a new strategic partnership with Elite Clinical Network (ECN) in a deal valued at approximately $200 million. ECN operates a network of phase I-IV clinical research sites throughout California, Arizona, Nevada and Texas, using advanced industry knowledge, practices and technology to move clinical trials efficiently from mandate to completion. It has completed thousands of studies for pharmaceutical companies and contract research organizations since launching in 2003.
Announced Sept. 8, this was the second major deal BakerHostetler helped SurgePE close in as many weeks, closely following our client’s acquisition of Tower Legal Solutions at the end of August. The team that helped facilitate SurgePE’s most recent deal includes:
Mergers and Acquisitions: Partner Patrick Rose, Counsel Allison Jones, and Associates Patrick Luthen, Patrick Dean, Nathan Henderson, Reed Leigh and Thomas Paquette.
Debt: Partners Adam Nazette and JR Lanis, and Associates Jamal Baghlani, David Corrigan and Chang Baek.
FDA/Healthcare: Partners Lee Rosebush, Lance Shea, Elise Barajas and Jenny Givens, Counsel Payal Cramer, and Associates Marc Wagner and Laura Macherelli.
Intellectual Property and Data Privacy: Partner Craig Carpenter.
Tax: Partner Michelle Hervey and Counsel Nicholas Mowbray.
Benefits: Partners Stefan Smith and Ann Caresani.
Real Estate: Associates Miranda Owens and Katie Gourley.
Employment: Partner Sabrina Shadi.
Hart Scott Rodino Antitrust Improvements Act: Partner Thomas Hogan and Associate Jeffrey Liskov.
Media coverage of the deal has included:
- PE Hub: “Surge Private Equity invests in Elite Clinical Network" (Sept. 11).
- Dallas Business Journal: “Dallas-based private equity firm makes $200M bet on clinical research firm" (Sept. 11).
- Mergermarket: “Elite Clinical Network secures USD 200m investment from Surge Private Equity (Sept. 11).
- The Texas Lawbook: "CDT Roundup: 16 Deals, 13 Firms, 165 Lawyers, $6.8B" (Oct. 24).
Subscriptions needed.